Syndrome of pleural and retrosternal "bridging" fibrosis and retroperitoneal fibrosis in patients with asbestos exposure

Cottin, V.; Brillet, P.-Y.; Combarnous, F.; Duperron, F.; Nunes, H.; Cordier, J.-F.
February 2008
Thorax;Feb2008, Vol. 63 Issue 2, p177
Academic Journal
Two case histories are described of pleural and anterior mediastinal fibrosis presenting as a continuous fibrotic process with thick parietal pleural plaques extending from one pleura to the contralateral pleura through the retrosternal area, and with retroperitoneal fibrosis. Follow-up over 4 years in one case demonstrated rapid progression of disease, with pleural fibrosis preceding retrosternal and retroperitoneal fibrosis. Histopathological analysis in both cases showed non-tumoral fibrosis with broad fibrous bundles surrounding fibroblasts (and lymphocytes in one case). Possible causes such as infections and exposure to ergot derivatives were excluded. Both patients had been slightly or moderately exposed to asbestos. These cases represent an unusual new presentation of pleural and retrosternal fibrosis extending beyond the anatomical structures and associated with retroperitoneal fibrosis.


Related Articles

  • Idiopathic retroperioneal fibrosis.  // British Medical Journal (Clinical Research Edition);4/25/1981, Vol. 282 Issue 6273, p1343 

    Examines the pathogenesis of idiopathic retroperitoneal fibrosis. Treatment with the use of ureterolysis; Chronic inflammation of connective tissues; Infiltration of lymphocytes and plasma cells.

  • Retroperitoneal fibrosis. Tzou, Martha; Gazeley, David J; Mason, Peter J // Vascular Medicine;Oct2014, Vol. 19 Issue 5, p407 

    Retroperitoneal fibrosis (RPF) is a rare disease that is marked by systemic inflammation and the development of a periaortic fibroinflammatory mass. The fibroinflammatory infiltration can encase the abdominal aorta, ureters, and other abdominal organs. The clinical presentation often includes...

  • Retroperitoneal fibrosis treated with tamoxifen. Owens, Lewis V.; Gance, William C. // American Surgeon;Sep1995, Vol. 61 Issue 9, p842 

    Presents a case study of a patient with retroperitoneal fibrosis (RF) who was successfully treated with tamoxifen. Characteristics of RF; Difficulties involvement in the treatment of RF; Effectiveness of tamoxifen in the treatment of dermoid tumors.

  • 18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnosis and Post-Therapeutic Treatment in a Patient with an Early Stage of Retroperitoneal Fibrosis. Asabella, Artor Niccoli; Nicoletti, A.; Altini, C.; Notaristefano, A.; Lastilla, G.; Rubini, G. // Molecular Imaging & Radionuclide Therapy;Aug2013, Vol. 22 Issue 2, p60 

    Here, we report an experience about 18F-FDG-PET/CT in a patient with an early stage of Idiopathic Retroperitoneal Fibrosis (IRF). At the diagnosis Contrast Enhanced Computed Tomography (CE-CT) revealed periaortic solid tissue in the infrarenal section and locoregional lymph nodes; findings were...

  • Two-years follow-up of low-dose methotrexate and 6-methylprednisolone therapy in a patient with idiopathic retroperitoneal fibrosis. SCAVALLI, A. SILI; DI ROCCO, G.; GIANNOTTI, D.; PATRIZI, G.; FREZZOTTI, F.; BERNIERI, M. G.; CANTISANI, V.; REDLER, A. // European Review for Medical & Pharmacological Sciences;2012, Vol. 16 Issue 15, p2171 

    Retroperitoneal fibrosis (RPF), also known as Ormond's disease, is a rare fibro-inflammatory disease with uncertain etiology. RPF is characterized by the presence of a particular retroperitoneal fibrotic tissue which is white, woody and involving retroperitoneal structures such as the great...

  • Tamoxifen.  // Reactions Weekly;7/13/2013, Issue 1461, p35 

    An abstract of the article "Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis," by Van Bommel EFH and colleagues is presented.

  • Oxprenolol and retroperitoneal fibrosis.  // British Medical Journal;11/29/1980, Vol. 281 Issue 6253, p1459 

    Presents a case report on the occurrence of retroperitoneal fibrosis in patients taking oxprenolol in Great Britain. Symptoms felt by the patients; Factors influencing the patients to take oxprenolol; Analysis of the case.

  • Systemic extrapancreatic lesions associated with autoimmune pancreatitis. Ohara, Hirotaka; Nakazawa, Takahiro; Ando, Tomoaki; Joh, Takashi // Journal of Gastroenterology;Apr2007 Supplement 18, Vol. 42, p15 

    Autoimmune pancreatitis (AIP) is frequently associated with sclerosing cholangitis (SC). SC with AIP has a cholangiographic appearance that is often confused with primary sclerosing cholangitis (PSC) but only the former responds well to corticosteroid therapy. Detailed study of cholangiographic...

  • Japanese consensus guidelines for management of autoimmune pancreatitis: II. Extrapancreatic lesions, differential diagnosis. Kawa, Shigeyuki; Okazaki, Kazuichi; Kamisawa, Terumi; Shimosegawa, Toru; Tanaka, Masao // Journal of Gastroenterology;Apr2010, Vol. 45 Issue 4, p355 

    The article offers guidelines in managing autoimmune pancreatitis (AIP). It highlights the types of extrapancreatic lesions related to AIP, including hilar lymphadenopathy, interstitial pnuemonitis, and retroperitoneal fibrosis. It mentions that these lesions are diagnosed through clinical...


Read the Article


Sign out of this library

Other Topics